Gammaherpesviruses and Lymphoproliferative Disorders

Annual Review of Pathology: Mechanisms of Disease - Tập 9 Số 1 - Trang 349-372 - 2014
Ethel Cesarman1
1Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10065

Tóm tắt

Epstein–Barr virus (EBV) and Kaposi's sarcoma herpesvirus (KSHV), formally designated human herpesvirus 4 (HHV-4) and 8 (HHV-8), respectively, are viruses that can cause a variety of cancers in humans. EBV is found in non-Hodgkin and Hodgkin lymphomas, as well as in lymphoproliferative disorders, which occur more commonly but not exclusively in individuals with immunodeficiency. EBV also causes nonlymphoid malignancies such as nasopharyngeal carcinoma. KSHV causes primary effusion lymphomas, multicentric Castleman's disease, and Kaposi's sarcoma. The frequency of lymphoid malignancies related to infection by one of these two herpesviruses is greatly increased in individuals with immunodeficiency, whether primary or acquired, for example, as a consequence of HIV infection and AIDS or in the case of therapeutic immunosuppression for organ transplantation. Our current understanding indicates that EBV and KSHV contribute to lymphomagenesis by affecting genomic stability and by subverting the cellular molecular signaling machinery and metabolism to avoid immune surveillance and enhance tumor cell growth and survival. Understanding the viral associations in specific lymphoproliferative disorders and the molecular mechanisms of viral oncogenesis will lead to better prevention, diagnosis, and treatment strategies for these diseases.

Từ khóa


Tài liệu tham khảo

10.1002/bjs.18004619704

10.1007/978-1-4614-4313-1_1

10.1016/S0140-6736(64)91524-7

10.1016/S0140-6736(73)92825-0

10.1007/978-1-4614-4313-1_11

10.1038/ng.2468

10.1038/ng.2469

10.1038/nature11378

10.1200/JCO.2008.20.5450

10.1200/JCO.2009.27.7087

10.1200/JCO.2010.28.0305

10.1097/MOH.0b013e3283623d7f

10.1182/blood-2010-10-310995

Swerdlow SH, 2008, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues

15. Kluin PM, Harris NL, Stein H, Leoncini L, Raphaël M, et al. 2008. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. See Ref. 14, pp. 265–66

10.1056/NEJMoa055759

10.1056/NEJMoa055351

10.1200/JCO.1988.6.8.1285

10.1002/cncr.11459

10.1097/COH.0b013e32831a722b

21. Raphaël M, Said J, Borisch B, Cesarman E, Harris NL. 2008. Lymphomas associated with HIV infection. See Ref. 14, pp. 340–42

10.1182/blood.V89.4.1413

23. Stein H, Harris NL, Campo E. 2008. Plasmablastic lymphoma. See Ref. 14, pp. 256–57

24. Swerdlow SH, Webber SA, Chadburn A, Ferry JA. 2008. Post-transplant lymphoproliferative disorders. See Ref. 14, pp. 343–49

Nalesnik MA, 1988, Am. J. Pathol., 133, 173

10.1182/blood.V85.2.552.552

10.1016/j.humpath.2006.08.014

10.1200/JCO.1998.16.6.2052

10.3109/10428190009054881

10.1007/s12185-008-0021-7

31. Quintanilla-Martinez L, Kimura H, Jaffe ES. 2008. EBV-positive T-cell lymphoproliferative disorders of childhood. See Ref. 14, pp. 278–80

10.3389/fimmu.2011.00054

10.1097/MOH.0b013e328353fa13

Filipovich AH, 1992, Cancer Res., 52, S5465

10.1002/ajh.21903

10.1182/blood-2010-03-272351

37. VanKrieken JH, Onciu M, Elenitoba-Johnson KSJ, Jaffe ES. 2008. Lymphoproliferative diseases associated with primary immune disorders. See Ref. 14, pp. 336–39

10.1038/nrc1452

10.1038/sj.onc.1210240

10.1038/nm758

10.1371/journal.ppat.1000341

Komano J, 1999, J. Virol., 73, 9827, 10.1128/JVI.73.12.9827-9831.1999

10.1128/JVI.74.21.10223-10228.2000

10.1002/jcp.21480

10.1093/emboj/19.24.6742

10.3109/08830185.2012.748053

10.1371/journal.ppat.0020023

10.1128/JVI.02244-06

10.1371/journal.ppat.1001063

10.1182/blood.V90.3.1186

10.1099/0022-1317-79-6-1445

10.1093/annonc/5.suppl_1.S113

Kieff E, 2007, Fields Virology, 2603

10.1002/j.1460-2075.1996.tb00674.x

10.1073/pnas.1832776100

10.1073/pnas.2336099100

10.1016/j.virol.2005.11.021

10.1073/pnas.79.24.7824

10.1073/pnas.88.12.5413

10.1182/blood.V82.3.920.920

10.1073/pnas.91.16.7568

10.1126/science.7725102

10.1016/0092-8674(85)90256-9

10.1073/pnas.95.20.11963

10.1016/j.cell.2011.12.031

10.1093/emboj/16.21.6478

10.1093/emboj/17.6.1700

Eliopoulos AG, 1999, J. Virol., 73, 1023, 10.1128/JVI.73.2.1023-1035.1999

10.1182/blood-2007-03-080309

10.1056/NEJM199505043321802

10.1182/blood.V88.2.645.bloodjournal882645

10.1097/01.pas.0000138177.10829.5c

10.1016/S0002-9440(10)65749-5

10.1182/blood-2002-10-3090

10.1073/pnas.1630810100

Ballon G, 2006, Viral and Immunological Malignancies

10.1080/02841860410002752

10.1182/blood.V86.4.1276.bloodjournal8641276

10.1002/ajh.10022

10.1046/j.1440-1827.2001.01266.x

10.1182/blood.V95.4.1406.004k26_1406_1412

10.1073/pnas.96.8.4546

10.1182/blood.V97.7.2130

Parravicini C, 1997, Am. J. Pathol., 151, 1517

10.1086/314956

Staskus KA, 1999, J. Virol., 73, 4181, 10.1128/JVI.73.5.4181-4187.1999

10.1309/7243-AV50-KJ28-V6J9

10.1086/654798

10.1182/blood-2002-02-0487

10.1007/BF02982069

10.1080/1042819031000104015

10.1080/10428190400018364

10.1007/s12185-009-0343-0

Saini N, 2013, Case Rep. Oncol. Med., 2013, 292301

10.1158/0008-5472.CAN-07-5126

10.1016/j.chom.2011.09.012

Carbone A, 1998, Blood, 91, 747

10.1038/80459

10.1038/47266

10.1007/s00109-003-0519-7

10.1038/sj.onc.1210299

10.1128/JVI.75.1.458-468.2001

10.1016/j.virol.2006.03.037

10.1128/JVI.78.19.10348-10359.2004

10.1182/blood.V99.2.649

10.1182/blood-2007-09-110544

Rainbow L, 1997, J. Virol., 71, 5915, 10.1128/jvi.71.8.5915-5921.1997

Godden-Kent D, 1997, J. Virol., 71, 4193, 10.1128/jvi.71.6.4193-4198.1997

Li M, 1997, J. Virol., 71, 1984, 10.1128/jvi.71.3.1984-1991.1997

10.1093/emboj/18.3.644

10.1093/emboj/18.3.654

10.1016/S1535-6108(02)00123-X

10.1158/0008-5472.CAN-03-1863

10.1038/ncb1735

10.1371/journal.ppat.1000818

10.1038/386517a0

10.1038/sj.onc.1202976

10.1073/pnas.0308016101

10.1038/sj.embor.7400580

10.1242/jcs.00691

10.1084/jem.190.7.1025

10.1084/jem.20031467

10.1182/blood-2004-08-3052

10.1038/ncb1980

10.1073/pnas.0408577102

10.1172/JCI44417

10.4161/cbt.10.10.13291

10.1128/JVI.77.15.8532-8540.2003

10.1016/j.tim.2010.04.001

10.1128/JVI.75.1.429-438.2001

10.1074/jbc.M309485200

10.1126/science.274.5293.1739

10.1074/jbc.272.31.19625

10.1038/nm0397-287

10.1128/JVI.02723-09

Sadler R, 1999, J. Virol., 73, 5722, 10.1128/JVI.73.7.5722-5730.1999

10.1128/JVI.76.23.11880-11888.2002

10.1126/science.1105779

Muralidhar S, 1998, J. Virol., 72, 4980, 10.1128/JVI.72.6.4980-4988.1998

10.1016/S1097-2765(01)00227-1

10.1128/JVI.01521-07

10.1128/MCB.18.9.5219

10.1128/JVI.77.17.9346-9358.2003

10.1128/JVI.76.2.802-816.2002

10.1038/nm0498-435

10.1093/jnci/94.12.926

10.1128/JVI.78.4.1918-1927.2004

10.1182/blood-2004-07-2781

10.1128/JVI.74.1.436-446.2000

10.1073/pnas.0408192102

10.1128/JVI.79.14.9301-9305.2005

10.1038/nmeth746

10.1261/rna.2326106

10.3389/fmicb.2012.00165

10.1038/ncb2019

10.1128/JVI.00202-10

10.1128/JVI.01804-07

10.1038/nature05992

10.1371/journal.pone.0049435

10.1128/JVI.01473-12

10.1371/journal.ppat.1002884

10.1097/MOH.0b013e328339018c

10.1371/journal.pone.0010126

10.1016/j.canlet.2011.03.003

10.1017/CBO9780511545313.051

Sun SC, 2011, Curr. Top. Microbiol. Immunol., 349, 197

10.1007/978-0-387-29346-2_2

Thông tin
Thông tin xuất bản

Annual Review of Pathology: Mechanisms of Disease

Tập 9 Số 1

349-372

Thông tin tác giả